Onward Therapeutics Makes a Strategic Investment in EMERCell for Their NK Cell Technology for Immunotherapy ...Middle East

LAUSANNE, Switzerland, Feb. 17, 2021 /PRNewswire/ -- Onward Therapeutics SA (Onward) announced today the execution of a strategic investment in EMERCell SAS, Montpellier, France, a company that has developed a platform technology to produce off-the-shelf natural killer (NK) cells. The...

Hence then, the article about onward therapeutics makes a strategic investment in emercell for their nk cell technology for immunotherapy was published today ( Wednesday 17/02/2021 - 09:15 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Onward Therapeutics Makes a Strategic Investment in EMERCell for Their NK Cell Technology for Immunotherapy )

Also on site :

• This CEO became 3x more productive with AI. Then she read what her daughter wrote about it at Dartmouth
• Robby Starbuck Calls John Cornyn's 'Keyboard Warrior' BLUFF With EPIC Challenge and We Are Here FOR IT
• Understanding Supplements for Toenail Fungus: PureHealth Research Highlights Oregano, Turmeric, and Olive Leaf